Skip to main content
DNA Labs India

ESRRB Gene Deafness, autosomal recessive type 35 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

ESRRB Gene Deafness, autosomal recessive type 35 NGS Genetic Test

Short Name: ESRRB DFNB35 NGS Test

Also known as: DFNB35 Genetic Test, Autosomal Recessive Deafness Type 35, ESRRB-Related Hearing Loss Test, ESRRB Gene Sequencing Test, Hereditary Hearing Loss DFNB35 Panel

ESRRB Gene Deafness, autosomal recessive type 35 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Reports will be delivered via the online portal, email, or WhatsApp.. Free home collection in 300+ cities across India.

NGS Genetic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the ESRRB Gene Deafness (DFNB35) NGS Genetic Test is to identify pathogenic or likely pathogenic mutations in the ESRRB gene that cause autosomal recessive sensorineural hearing loss. This test enables accurate molecular diagnosis, confirms clinical suspicion of DFNB35, facilitates carrier detection in family members, supports informed genetic counseling and family planning, and guides early clinical intervention strategies including audiological management and rehabilitation.

Test Code
2339
CPT Code
81479
ICD Code
H90.3
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Reports will be delivered via the online portal, email, or WhatsApp.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation or fasting is required. Ensure the patient's clinical history, family pedigree information, and any previous audiological or genetic test results are available for the referring geneticist.

Method: Venipuncture

Step 2

Laboratory Analysis

A venipuncture blood draw of approximately 3-5 mL will be collected in an EDTA (lavender top) tube. Alternatively, a single drop of blood on an FTA card or an extracted DNA sample may be used. The procedure typically takes 5-10 minutes.

Step 3

Report Delivery

Apply pressure to the venipuncture site with a cotton ball or gauze for 3-5 minutes. Avoid heavy lifting with the arm used for the draw for the remainder of the day. The sample will be transported under appropriate conditions to the laboratory for processing.

Timeline: Results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Reports will be delivered via the online portal, email, or WhatsApp.

Patient Instructions

1
Before the Test:No fasting is required. Provide complete clinical history including onset, progression, and severity of hearing loss. Inform the genetic counselor about family history of hearing loss, consanguinity, and any previous genetic test results. A pre-test genetic counseling session will be conducted to draw a family pedigree and discuss the implications of testing.
2
During the Test:A blood sample of approximately 3-5 mL will be drawn from a vein in the arm using a sterile needle and collected in an EDTA tube. Alternatively, a blood drop on an FTA card or previously extracted DNA may be submitted. The collection process is quick and minimally invasive, taking approximately 5-10 minutes. Free home sample collection is available across India.
3
After the Test:After sample collection, slight bruising at the venipuncture site may occur and typically resolves within a few days. The sample will be sent to the laboratory for NGS analysis. Results will be available within 3 to 4 weeks. A genetic counselor will contact you to explain the findings and discuss any recommended next steps, including further testing, management options, or family screening.

About This Test

Who Should Get This Test

The purpose of the ESRRB Gene Deafness (DFNB35) NGS Genetic Test is to identify pathogenic or likely pathogenic mutations in the ESRRB gene that cause autosomal recessive sensorineural hearing loss. This test enables accurate molecular diagnosis, confirms clinical suspicion of DFNB35, facilitates carrier detection in family members, supports informed genetic counseling and family planning, and guides early clinical intervention strategies including audiological management and rehabilitation.

How to Prepare

  • Blood sample should be collected in an EDTA (lavender top) vacutainer tube
  • If using an FTA card, ensure a single drop of blood is applied correctly and allowed to dry completely
  • Label the sample clearly with patient name, date of birth, and sample ID
  • Store the blood sample at room temperature (18-25°C) and transport within 48 hours of collection
  • Avoid freezing the whole blood sample prior to DNA extraction
  • Ensure all required consent forms and clinical history documentation accompany the sample

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"ESRRB gene mutations are a recognized cause of non-syndromic autosomal recessive sensorineural hearing loss. For couples with a family history of hereditary deafness or consanguineous marriages, genetic testing for DFNB35 can provide critical information for family planning, early intervention with hearing aids or cochlear implants, and long-term management. I recommend this test for any individual presenting with unexplained bilateral sensorineural hearing loss with suspected genetic etiology."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume3-5 mL Whole Blood
ContainerEDTA (Lavender Top) Tube or FTA Card
Collection MethodVenipuncture

Sample Stability

Whole blood in EDTA tube: Stable at room temperature (18-25°C) for up to 7 days
Extracted DNA: Stable at 2-8°C for up to 6 months; at -20°C for long-term storage
FTA Card: Stable at room temperature for several years when stored in a sealed bag with desiccant
Sample Rejection Criteria:
  • Sample collected in heparin tube (heparin inhibits downstream molecular reactions)
  • Insufficient sample volume (less than 1 mL whole blood)
  • Heavily hemolyzed, clotted, or contaminated sample
  • Sample received without proper labeling or patient identification
  • Sample received more than 7 days after collection without appropriate preservation
  • Missing or incomplete consent form or clinical history documentation

Understanding Your Results

The results of the ESRRB Gene Deafness (DFNB35) NGS Genetic Test will indicate whether pathogenic, likely pathogenic, or variants of uncertain significance (VUS) have been identified in the ESRRB gene. Results must be interpreted by a qualified geneticist or genetic counselor in the context of the patient's clinical presentation, family history, and audiological findings. A genetic counseling session is included with this test to help patients and families understand the implications of the results.
📊

No pathogenic variants detected

No disease-causing mutations were identified in the ESRRB gene. This result does not completely exclude a genetic basis for hearing loss, as other genes may be responsible. Further genetic evaluation with a comprehensive hearing loss gene panel may be considered.

📊

Pathogenic or likely pathogenic variant(s) detected — homozygous or compound heterozygous

Two pathogenic or likely pathogenic variants were identified in the ESRRB gene in a homozygous or compound heterozygous state. This is consistent with a molecular diagnosis of DFNB35 (Deafness, Autosomal Recessive Type 35). Genetic counseling is recommended to discuss inheritance patterns, recurrence risks, and management options.

📊

Single pathogenic or likely pathogenic variant detected — heterozygous carrier

A single pathogenic or likely pathogenic variant was identified, indicating carrier status for DFNB35. Carriers typically do not exhibit hearing loss but can pass the variant to offspring. Partner testing and genetic counseling are recommended for family planning purposes.

📊

Variant(s) of uncertain significance (VUS) detected

One or more variants were identified in the ESRRB gene whose clinical significance cannot be determined at this time. VUS should not be used for clinical decision-making. Periodic reclassification may occur as new evidence becomes available. Genetic counseling and clinical correlation are advised.

⚠️ When to Consult a Doctor:

Consult your doctor or genetic counselor if you or your child experience unexplained hearing loss or delayed speech development, if there is a family history of hereditary deafness, if you are planning a pregnancy and have a known family history of DFNB35 or ESRRB mutations, or if your genetic test results indicate pathogenic variants or carriership. Early consultation enables timely intervention, appropriate audiological management, and informed family planning.

Limitations

  • This test is specific to the ESRRB gene and does not screen for mutations in other hearing loss-associated genes
  • Deep intronic variants, regulatory region mutations, and large deletions/duplications may not be fully detected
  • Variants of uncertain significance (VUS) require further clinical correlation and may change in classification over time
  • A negative result does not completely exclude a genetic cause of hearing loss as other genes may be involved
  • Mosaicism at low levels may not be reliably detected by this assay
  • Results should always be interpreted in conjunction with clinical findings, family history, and audiological evaluation

Risks & Considerations

  • Minor bruising or discomfort at the venipuncture site
  • Slight risk of infection at the blood draw site (rare with standard sterile technique)
  • Emotional or psychological impact of genetic test results; genetic counseling is provided to support the patient

Interfering Factors

  • Degraded or insufficient DNA quality in the sample may affect sequencing results
  • Blood transfusion within the past 4 weeks may interfere with genetic analysis
  • Hemolysis in the blood sample may reduce DNA yield and quality
  • Contamination during sample collection or transport may compromise results
  • Large structural rearrangements or copy number variants may not be fully detected by standard NGS

Compare With Similar Tests

TestESRRB Gene Deafness, autosomal recessive type 35 NGS Genetic TestGJB2 Gene SequencingComprehensive Hearing Loss Gene PanelSLC26A4 Gene Test (Pendred Syndrome / DFNB4)Microarray-Based CGH (Chromosomal Microarray)
ComparisonESRRB Gene Deafness, autosomal recessive type 35 NGS Genetic Test

Frequently Asked Questions

What is ESRRB Gene Deafness (DFNB35)?
ESRRB Gene Deafness, also known as Deafness, Autosomal Recessive Type 35 (DFNB35), is a genetic form of non-syndromic sensorineural hearing loss caused by mutations in the ESRRB gene. This gene provides instructions for making the estrogen-related receptor beta (ERR?) protein, which is essential for the normal development and function of the inner ear's cochlea. The condition is inherited in an autosomal recessive pattern.
How is the ESRRB Gene Deafness NGS Genetic Test performed?
The test uses Next-Generation Sequencing (NGS) technology to analyze the ESRRB gene for disease-causing mutations. A blood sample (approximately 3-5 mL in an EDTA tube), extracted DNA, or a single drop of blood on an FTA card is collected and processed in the laboratory. NGS allows high-throughput, accurate sequencing of the entire coding region and splice sites of the ESRRB gene.
Who should consider getting the ESRRB Gene Deafness test?
This test is recommended for individuals with unexplained bilateral sensorineural hearing loss, children with delayed speech development, newborns who fail hearing screening, individuals with a family history of hereditary deafness, couples from consanguineous marriages planning a family, and anyone seeking carrier status determination for DFNB35.
What does a positive test result mean?
A positive result means that pathogenic or likely pathogenic mutations in the ESRRB gene were identified. If two mutations are found in a homozygous or compound heterozygous state, this confirms a diagnosis of DFNB35. A genetic counselor will explain the implications, discuss inheritance patterns, and recommend management options including audiological intervention.
What does a negative test result mean?
A negative result means no pathogenic mutations were detected in the ESRRB gene. However, this does not completely exclude a genetic cause of hearing loss, as mutations in other genes may be responsible. Your doctor may recommend further genetic testing, such as a comprehensive hearing loss gene panel, to identify the underlying cause.
What is the cost of the ESRRB Gene Deafness NGS Genetic Test?
The cost of the ESRRB Gene Deafness (DFNB35) NGS Genetic Test at DNA Labs India is INR 20,000. This price includes the NGS genetic testing, bioinformatics analysis, result interpretation by a qualified geneticist, a genetic counseling session, and free home sample collection.
How long does it take to receive the test results?
Test results are typically available within 3 to 4 weeks from the date of sample receipt at the laboratory. Reports are delivered through the online portal, email, or WhatsApp for your convenience.
Is home sample collection available for this test?
Yes, DNA Labs India offers free home sample collection for the ESRRB Gene Deafness NGS Genetic Test across numerous cities in India including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, Pune, Ahmedabad, and many more. You can book a home collection appointment online.
Can this test be used for prenatal diagnosis?
Prenatal diagnosis for DFNB35 is possible if the specific ESRRB mutations in the family have been previously identified. Prenatal testing requires specialized sample collection (such as chorionic villus sampling or amniocentesis) and should be discussed with your obstetrician and genetic counselor. The ESRRB NGS test itself is typically performed on postnatal blood or DNA samples.
Is the ESRRB Gene Deafness test the same as a comprehensive hearing loss panel?
No. The ESRRB Gene Deafness test specifically analyzes the ESRRB gene for DFNB35-related mutations. A comprehensive hearing loss gene panel screens 80 to 150+ genes associated with hereditary hearing loss, providing broader diagnostic coverage. If clinical suspicion for DFNB35 is not specific, a comprehensive panel may be more appropriate.
How is DFNB35 inherited, and what is the recurrence risk for future children?
DFNB35 is inherited in an autosomal recessive pattern. Both parents must be carriers of an ESRRB gene mutation (each carrying one mutated copy) for a child to be affected. If both parents are carriers, there is a 25% chance with each pregnancy that the child will be affected, a 50% chance the child will be a carrier, and a 25% chance the child will be neither affected nor a carrier.
Is genetic counseling included with this test?
Yes, DNA Labs India includes a genetic counseling session with the ESRRB Gene Deafness NGS Genetic Test. A qualified genetic counselor will help you understand the test results, discuss inheritance patterns, provide guidance on management and treatment options, and advise on family planning implications. Pre-test counseling is also available to draw a family pedigree and discuss the benefits and limitations of testing.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.